These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33519208)

  • 1. Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets.
    Lv Y; Ma X; Du Y; Feng J
    Onco Targets Ther; 2021; 14():589-607. PubMed ID: 33519208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.
    Siddappa CM; Pillai SG; Snider J; Alldredge P; Trinkaus K; Watson MA; Aft R
    Breast Cancer Res Treat; 2019 Nov; 178(2):317-325. PubMed ID: 31432366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
    Contreras-Zárate MJ; Day NL; Ormond DR; Borges VF; Tobet S; Gril B; Steeg PS; Cittelly DM
    Oncogene; 2019 Jun; 38(24):4685-4699. PubMed ID: 30796353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes].
    Zhang T; Li Q; Xu B; Zhang P; Yuan P; Ma F; Wang J; Fan Y
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):697-702. PubMed ID: 25564062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
    Saraf A; Grubb CS; Hwang ME; Tai CH; Wu CC; Jani A; Lapa ME; Andrews JIS; Vanderkelen S; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJC
    J Neurooncol; 2017 Sep; 134(2):453-463. PubMed ID: 28674973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype.
    Shao F; Sun H; Deng CX
    Oncotarget; 2017 Sep; 8(42):73329-73344. PubMed ID: 29069872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and prognostic evaluation of bone metastasis in triple-negative breast cancer.
    Luo A; Wu F; Han R; Huang S; Zhang Y; Jing X; Zhao X
    J Cancer Res Ther; 2017; 13(5):778-784. PubMed ID: 29237903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.
    Apaya MK; Shiau JY; Liao GS; Liang YJ; Chen CW; Yang HC; Chu CH; Yu JC; Shyur LF
    J Exp Clin Cancer Res; 2019 May; 38(1):187. PubMed ID: 31072371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options.
    Nakhjavani M; Samarasinghe RM; Shigdar S
    Drug Discov Today; 2022 May; 27(5):1298-1314. PubMed ID: 35101641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions.
    Lee KL; Chen G; Chen TY; Kuo YC; Su YK
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple negative breast cancer - prognostic role of immune-related factors: a systematic review.
    Stovgaard ES; Nielsen D; Hogdall E; Balslev E
    Acta Oncol; 2018 Jan; 57(1):74-82. PubMed ID: 29168430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-stage targeted therapy for the brain metastasis from triple-negative breast cancer.
    Luo Z; Wu S; Zhou J; Xu W; Xu Q; Lu L; Xie C; Liu Y; Lu W
    Acta Pharm Sin B; 2023 Jan; 13(1):359-371. PubMed ID: 36815053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
    Qattan A
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database.
    Kim YJ; Kim JS; Kim IA
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1803-1816. PubMed ID: 29971531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion.
    Noonan MM; Dragan M; Mehta MM; Hess DA; Brackstone M; Tuck AB; Viswakarma N; Rana A; Babwah AV; Wondisford FE; Bhattacharya M
    Oncotarget; 2018 Jul; 9(53):30034-30052. PubMed ID: 30046386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of Extracellular Vesicles in Triple-Negative Breast Cancer.
    St-Denis-Bissonnette F; Khoury R; Mediratta K; El-Sahli S; Wang L; Lavoie JR
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer.
    Chen HA; Chang YW; Tseng CF; Chiu CF; Hong CC; Wang W; Wang MY; Hsiao M; Ma JT; Chen CH; Jiang SS; Wu CH; Hung MC; Huang MT; Su JL
    Ann Surg Oncol; 2015 Mar; 22(3):889-98. PubMed ID: 25212833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
    Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X
    Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes.
    Walsh EM; Keane MM; Wink DA; Callagy G; Glynn SA
    Crit Rev Oncog; 2016; 21(5-6):333-351. PubMed ID: 29431082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.